Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
ArabinoFuranosylGuanine [18F]F-AraG
Locations
1
United States
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
September 4, 2024
Primary Completion Date
October 1, 2027
Completion Date
October 1, 2027
Last Updated
November 10, 2025
NCT04674267
NCT07217704
NCT07464470
NCT07132918
NCT07367516
NCT06346080
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions